Master patient flow analysis to predict pharma demand and provide better patient access. | Evaluate
Key considerations for creating more accurate patient-based product forecasts.| Evaluate
Every year, I am hugely fortunate to work with our team of experts to create the Evaluate World Preview report. Now in its 18th year, the World Preview offers a data-rich look at the future of the pharmaceutical industry. It’s full of forecast data that help to paint a picture of the shifting sands of […] The post Three Things we Learned in our World Preview 2025 Webinar appeared first on Evaluate.| Evaluate
Recently, the J+D Forecasting team welcomed a diverse group of professionals to Boston for our two-day Fundamentals of Forecasting multi-client workshop, run in collaboration with Evaluate. From emerging clinical-stage biotechs to global Top 10 pharma companies, delegates gathered to deepen their knowledge, share experiences, and engage in peer-to-peer learning in a relaxed, collaborative environment. The […] The post Inside the Fundamentals of Forecasting: Highlights from Our Boston Worksh...| Evaluate
Key considerations for creating more accurate patient-based product forecasts.| Evaluate
The board at Verona Pharma was taking the steps necessary to take its chronic obstructive pulmonary disorder (COPD) drug to market years ahead of its launch in 2024. This long term view was one of the details shared by Verona’s Chief Commercial Officer, Chris Martin during our recent webinar “Going Solo: What’s Driving the Biotech […] The post Three Things we Learned in our Biotech Commercialization Webinar appeared first on Evaluate.| Evaluate
“Think twice, and twice more, before launching your own drug. It is unimaginably difficult and complex”. Those were the words of a biotech CEO I interviewed more than a decade ago. The advice remains sound. Yet today there are tailwinds encouraging more biotechs to take their prized assets all the way to market. (And let’s […] The post A Blueprint for Biotech Commercialization? appeared first on Evaluate.| Evaluate
When it comes to forecasting sales in the pharmaceutical industry, several time series algorithms are commonly used to analyze historical data and project trends into the future. These can be classified into three main types: Automated Smoothing First is the automated smoothing algorithm. This includes techniques such as growth rates and linear regression. Smoothing algorithms […] The post Choosing the most Appropriate Time Series Algorithm for Accurate Pharmaceutical Sales Forecasts appear...| Evaluate
Discover 3 key insights from our webinar on first to market advantage in the pharma industry. Learn how these findings can impact your portfolio strategy.| Evaluate
For Portfolio Strategy teams in pharma companies, there is a constant juggling act to ensure that the right therapies are being prioritized for the right indications. This requires a clear understanding of the potential market size, payer perspectives and competitive environment. With the right data and insight, you can plan your go-to-market approach – and […] The post Should Pharma Companies Really Race to be First to Market? appeared first on Evaluate.| Evaluate
In our webinar about long-range planning processes in pharma we looked at the foundational pieces you need to achieve accurate forecasts| Evaluate
Competitive Intelligence teams occupy quite a unique place in a biopharma organization. They collaborate with a really wide range of stakeholders – sales, regulatory, forecasting and many more. This gives CI professionals insight into countless strategic initiatives across the company. But it also means trying to support a lot of different, sometimes almost contradictory needs. […] The post The High-Stakes Landscape for Competitive Intelligence appeared first on Evaluate.| Evaluate
